s-nitrosoglutathione has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aranda, E; Corrales, FJ; López-Pedrera, C; López-Sánchez, LM; Rodríguez-Ariza, A | 1 |
| Calmels, S; Hainaut, P; Ohshima, H | 1 |
2 other study(ies) available for s-nitrosoglutathione and Liver Neoplasms
| Article | Year |
|---|---|
Pharmacological impairment of s-nitrosoglutathione or thioredoxin reductases augments protein S-Nitrosation in human hepatocarcinoma cells.
Topics: Antirheumatic Agents; Auranofin; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Nitrosation; Plicamycin; Proteins; Proteomics; S-Nitrosoglutathione; Spectrometry, Mass, Electrospray Ionization; Thioredoxin-Disulfide Reductase; Tumor Cells, Cultured | 2010 |
Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein.
Topics: Breast Neoplasms; Carcinoma, Hepatocellular; DNA, Neoplasm; Glutathione; Humans; Liver Neoplasms; Nitric Oxide; Nitroso Compounds; Penicillamine; S-Nitroso-N-Acetylpenicillamine; S-Nitrosoglutathione; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1997 |